Mainline Instruments has appointed Jeff Landucci as its new commercial director of ophthalmic therapics to lead new and diversified projects and broaden its market presence.
Landucci’s appointment comes at an exciting time for the business as it enters a new exclusive partnership with InMode to distribute its innovative cutting-edge Envision platform for non-surgical dry eye treatments.
Jack Hawkins, managing director of Mainline Instruments, commented: ‘We’re excited to welcome Jeff to the team. His industry insight and technical knowledge will be instrumental as we look to the future. Over the past few years, we have consolidated growth through the expansion of our customer base and the addition of new supplier partnerships.’
